Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 251641 - 251660 out of 498644 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Greece | (L01FA01) rituximab | RUXIENCE C/S.SOL.IN 500MG/VIAL BTx1 vial | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell;Arthritis, Rheumatoid;Microscopic Polyangiitis;Pemphigus | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FA01) rituximab | MABTHERA INJ.SOL 1400MG/11.7ML BTxVIALx15ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FB01) inotuzumab ozogamicin | BESPONSA PD.C.S.INF 1MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FC01) daratumumab | DARZALEX C/S.SOL.IN 100mg/5ml VIAL BTx1 VIAL x5 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FC01) daratumumab | DARZALEX C/S.SOL.IN 400mg/20ml VIAL BTx1 VIAL x20 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FC01) daratumumab | DARZALEX INJ.SOL 1800MG/VIAL (120 MG/ML) BTx1VIAL x 15ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | JANSSEN-CILAGINTERN.NV.,BELGIUM |
| Greece | (L01FC02) isatuximab | SARCLISA C/S.SOL.IN 20MG/ML 1 VIAL x 25 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SANOFIWINTHROPINDUSTRIE,FRANCE |
| Greece | (L01FC02) isatuximab | SARCLISA C/S.SOL.IN 20MG/ML 1 VIAL x 5 ml | n/a | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SANOFIWINTHROPINDUSTRIE,FRANCE |
| Greece | (L01FD01) trastuzumab | HERCEPTIN INJ.SOL 600MG/5ML BTx1VIALx5ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FD01) trastuzumab | HERCEPTIN PD.C.SO.IN 150 MG/VIAL BTx1VIAL(GLASS) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
| Greece | (L01FD01) trastuzumab | HERZUMA PD.C.S.INF 150MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
| Greece | (L01FD01) trastuzumab | KANJINTI® PD.C.SO.IN 150MG/VIAL BT x 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (L01FD01) trastuzumab | ONTRUZANT® PD.C.S.INF 150MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | SAMSUNGBIOEPISNLB.V.,THENETHERLANDS |
| Greece | (L01FD01) trastuzumab | TRAZIMERA PD.C.SO.IN 150MG BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PFIZEREUROPEMAEEIG,BELGIUM |
| Greece | (L01FD01) trastuzumab | ZERCEPAC PD.C.SO.IN 150MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U.,SPAIN |
| Greece | (L01FD01) trastuzumab | HERZUMA PD.C.S.INF 420MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.,BUDAPEST,HUNGARY |
| Greece | (L01FD01) trastuzumab | KANJINTI PD.C.SO.IN 420MG/VIAL BT x 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | AMGENEUROPEBV,BREDA,HOLLAND |
| Greece | (L01FD01) trastuzumab | ONTRUZANT® PD.C.S.INF 420MG/VIAL BTx1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | SAMSUNGBIOEPISNLB.V.,THENETHERLANDS |
| Greece | (L01FD01) trastuzumab | ZERCEPAC PD.C.SO.IN 420MG/VIAL BTx 1 VIAL | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | ACCORDHEALTHCARES.L.U.,SPAIN |
| Greece | (L01FD02) pertuzumab | PERJETA C/S.SOL.IN 420MG/VIAL (30MG/ML) BTx1 VIAL x 14ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | ROCHEREGISTRATIONGMBH,GERMANY |
Pages
